FDA Accepts Merck’s Sac-TMT Application for Priority Review
The FDA accepted Merck’s biologics license application for sac-TMT for priority review.
Story updates
03:31:47 PM UTC
SquawkNews
FDA Grants Priority Review to Merck's Sac-TMT for Endometrial Cancer The FDA accepted Merck’s ap